/Woman%20scientist%20in%20lab%20looking%20at%20microscope%20medical%20test%20by%20aFotostock%20via%20Adobe%20Stock.jpeg)
Bio-Techne Corporation (TECH) is a global life sciences company headquartered in Minneapolis that develops, manufactures, and sells high-performance reagents, proteins, antibodies, diagnostic products, and analytical instruments used by researchers, biotechnology companies, pharmaceutical firms, and clinical laboratories worldwide. The company operates primarily through its Protein Sciences and Diagnostics and Spatial Biology segments, providing critical tools for drug discovery, cell and gene therapy development and precision medicine applications. The company has a market cap of around $9.1 billion.
Companies worth between $2 billion and $10 billion are generally classified as “mid-cap stocks,” and Bio-Techne fits this criterion perfectly. Bio-Techne has built a strong position as a “picks-and-shovels” supplier to the life sciences industry, benefiting from recurring demand for research consumables and specialized biological products.
